Advertisement

Search Results for "Pharma Companies In Baddi"

08:20 EDT 19th June 2013 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Sweden

The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...

Boehringer Ingelheim

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 c...

Matching News

Pharma 3.0 Pulls Companies into the Digital Future

Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0.  Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...

R&D pharma companies - comment from the Economist Intelligence Unit

Few people disagree that small drug discovery companies are vital to the health of the UK's pharma industry, and central to the government's aim of innovation-led growth. But private backers...

Who is determining the reputation of Pharma?

As corporate bodies, the reputation of pharma companies was typically of concern to shareholders, but generally determined by the industry or experts. Although a report just published, The Corporate...

Drugmakers offer to cap Greece's medicines bill - comment from the Economist Intelligence Unit

Pharmaceutical companies have long struggled to secure payment from Greek hospitals, whose debt problems predate the euro crisis. According to the Hellenic Association of Pharmaceutical Companies, t...

Pharma companies face EU fines over delays - comment from The Economist Intelligence Unit

“The combination of tightening healthcare budgets and widespread patent expiries is leading both the EU and US to crack down on perceived threats to competition in the pharma market. Many of t...

Drug industry productivity set to improve

The improvement in drug launches - and the drop in Phase III terminations - suggests that pharma companies' efforts to focus research funding only on the most promising area are paying dividends...

Are DTC Ads Falling Out of Favor with Pharma Companies?

With the Super Bowl only days away, all the chatter has turned to the most interesting aspect of this beloved American tradition — the TV ads.  What products will we see?  Whose commercial will be...

AstraZeneca big pharma deals Par Pharmaceutical for Atacand supply and distribution

AstraZeneca enters big pharma deals with Par Pharmaceutical Companies for an exclusive U.S. supply and distribution agreement in which Par will distribute the authorized generic version of AstraZeneca...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement